Gillian A. Horne

Identification of circulating microRNAs as diagnostic biomarkers for use in multiple myeloma

Christopher I. Jones, Maria V. Zabolotskaya, A. J. King et al. · British Journal of Cancer · 2012 · 134 citations · Full text

<scp>BRD</scp>4 associates with p53 in <scp>DNMT</scp>3A‐mutated leukemia cells and is implicated in apoptosis by the bromodomain inhibitor <scp>JQ</scp>1

Helen Stewart, Gillian A. Horne, Sarah Bastow et al. · Cancer Medicine · 2013 · 86 citations · Full text

A randomised phase II trial of hydroxychloroquine and imatinib versus imatinib alone for patients with chronic myeloid leukaemia in major cytogenetic response with residual disease

Gillian A. Horne, Jon Stobo, Caroline Kelly et al. · Leukemia · 2020 · 75 citations · Full text

Hematological Malignancy, Residual Disease, Imatinib Versus Imatinib +8

CD93 is expressed on chronic myeloid leukemia stem cells and identifies a quiescent population which persists after tyrosine kinase inhibitor therapy

Ross Kinstrie, Gillian A. Horne, Heather Morrison et al. · Leukemia · 2020 · 68 citations · Full text

Early Results of Endovascular Treatment of the Thoracic Aorta Using the Valiant Endograft

Matt Thompson, S. Ivaz, Nicholas Cheshire et al. · CardioVascular and Interventional Radiology · 2007 · 60 citations

Endovascular Technique, Endovascular Treatment, Composite Allograft +8